- Home
- ENOV vs CCU Comparison
ENOV vs CCU Comparison
Compare ENOV & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- CCU
- Stock Information
- Founded
- ENOV 1995
- CCU 1850
- Country
- ENOV United States
- CCU Chile
- Employees
- ENOV N/A
- CCU N/A
- Industry
- ENOV Fluid Controls
- CCU Beverages (Production/Distribution)
- Sector
- ENOV Industrials
- CCU Consumer Staples
- Exchange
- ENOV Nasdaq
- CCU Nasdaq
- Market Cap
- ENOV 2.1B
- CCU N/A
- IPO Year
- ENOV 2008
- CCU 1992
- Fundamental
- Price
- ENOV $33.10
- CCU $14.86
- Analyst Decision
- ENOV Buy
- CCU Strong Sell
- Analyst Count
- ENOV 4
- CCU 2
- Target Price
- ENOV $58.50
- CCU $9.70
- AVG Volume (30 Days)
- ENOV 986.0K
- CCU 192.7K
- Earning Date
- ENOV 05-08-2025
- CCU 05-20-2025
- Dividend Yield
- ENOV N/A
- CCU 3.11%
- EPS Growth
- ENOV N/A
- CCU 52.33
- EPS
- ENOV N/A
- CCU 0.44
- Revenue
- ENOV $2,150,191,000.00
- CCU $2,922,923,314.00
- Revenue This Year
- ENOV $7.13
- CCU $8.75
- Revenue Next Year
- ENOV $6.33
- CCU $3.51
- P/E Ratio
- ENOV N/A
- CCU $17.40
- Revenue Growth
- ENOV 18.32
- CCU 13.21
- 52 Week Low
- ENOV $29.32
- CCU $10.00
- 52 Week High
- ENOV $53.84
- CCU $15.75
- Technical
- Relative Strength Index (RSI)
- ENOV 41.77
- CCU 45.75
- Support Level
- ENOV $33.48
- CCU $15.01
- Resistance Level
- ENOV $35.62
- CCU $15.57
- Average True Range (ATR)
- ENOV 1.32
- CCU 0.38
- MACD
- ENOV 0.20
- CCU -0.05
- Stochastic Oscillator
- ENOV 49.20
- CCU 36.44
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.